NCT06915090

Brief Summary

In individuals with overweight/obesity, increases in physical activity (PA) can improve metabolic and cardiovascular health, independent of weight loss. However, PA levels are often low in individuals with overweight/obesity, and primary care providers (PCPs) are tasked with addressing this issue. The investigative team developed and successfully piloted integrating a Fitbit program into clinical care, where patients were referred by PCPs, and PCPs could view PA data in the Epic electronic health record. Though feasible, PCPs wanted additional support for PA management. We also acknowledge the role of pharmacotherapy (GLP-1 agonists and GIPs) in clinical care for patients with overweighr and obesity, and the added support these patients may need. The investigative team proposes a reimbursable service of a health coach to work collaboratively with PCPs, to deliver a Fitbit-supported PA program to patients with overweight/obesity who have been prescribed a weight loss medication. In Aim 1, the team will enroll PCPs to refer patients to a 12-week health coaching program. In Aim 2, the team will conduct interviews with enrolled patients/PCPs to understand their perspectives on the program, and with new sites to establish relationships for a future R01 submission.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 25, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 8, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

March 25, 2025

Last Update Submit

December 11, 2025

Conditions

Keywords

GLP-1DiabetesObesityHealth CoachPhysical ActivityBody Composition

Outcome Measures

Primary Outcomes (1)

  • Feasibility of enrollment

    The number of enrolled patients in the study.

    6-months

Secondary Outcomes (9)

  • Engagement with intervention

    3-months

  • Average steps per day

    Baseline, 3-months

  • Short-Form 12 Question Health-related Quality of Life

    Baseline, 3-months

  • Numeric Pain Rating Scale (NPRS)

    Baseline, 3-months

  • Muscle Strengthening Activities

    Baseline, 3-months

  • +4 more secondary outcomes

Study Arms (1)

GLP-1/Coaching Arm

EXPERIMENTAL

Patients enrolled in this arm will complete assessments at baseline and 3-months, and receive a 12-week health coaching intervention (up to 6 virtual sessions with health coach) in addition to a Fitbit wearable device.

Behavioral: Health Coach/Fitbit

Interventions

Health coach visits (up to 6) will be conducted virtually and include: Session 1: * Assessment, wellness vision, * Habits and goals (Stretching, strength training, cardiovascular PA/walking, Diet) * Motivation, resources, and guidelines * Online program orientation * Set first week's goals Sessions 2-5: -Goal review, successes and challenges, new goal setting (i.e. Increase steps by 1,000/day if consistently meeting goal) Session 6 -Review of progress, maintenance plan, final assessment

GLP-1/Coaching Arm

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI ≥27-45
  • Prescribed a GLP-1/GIP within the past 6 months
  • Currently taking GLP/GIP
  • Age 18 years of age and older
  • Patient of UMass Medical Group Primary Care Clinic
  • Speaks and reads English

You may not qualify if:

  • BMI \<27 or ≥45
  • Not currently taking GLP-1/GIP
  • Under 18 years of age
  • Prescribed GLP-1/GIP for less than 6 months
  • Not a patient of UMass Medical Group Primary Care Clinic
  • Does not speak English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMass Chan Medical School

Worcester, Massachusetts, 01605, United States

Location

MeSH Terms

Conditions

Diabetes MellitusObesityCardiovascular DiseasesMotor Activity

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 25, 2025

First Posted

April 8, 2025

Study Start

March 18, 2025

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

We will share de-identified data upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
1 year afte the study ends.
Access Criteria
We will share de-identified data upon reasonable request.

Locations